APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Reproductive Hormone

Reproductive hormones are usually made in the ovaries (in females) and testes (in males)，which use to helping develop and maintain female and male sex characteristics and play an important role in the menstrual cycle, fertility, and pregnancy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Reproductive hormones are usually made in the ovaries (in females) and testes (in males)，which use to helping develop and maintain female and male sex characteristics and play an important role in the menstrual cycle, fertility, and pregnancy.

Selected research

Market Outlook & Growth Opportunities

Global Reproductive Hormone Market Outlook and Growth Opportunities 2026

Report ID 173895390431 December 2025197 pages

Choose your research edition.

Industry ResearchReproductive Hormone Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Reproductive Hormone Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Reproductive Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Reproductive Hormone Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Reproductive Hormone Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Reproductive hormones are usually made in the ovaries (in females) and testes (in males)，which use to helping develop and maintain female and male sex characteristics and play an important role in the menstrual cycle, fertility, and pregnancy.

Globally, the reproductive hormone industry market is relatively concentrated because of the R&D barrier. And some enterprises, like Pfizer,MERCK SERONO and ABBVIE etc.

This report provides an overview of the global Reproductive Hormone market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Reproductive Hormone and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Reproductive Hormone revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Reproductive Hormone market.

Reproductive Hormone Segment by Company

Pfizer

MERCK Groups

ABBVIE

Bayer

Endo Pharmaceuticals

Mayne Pharma

Jenapharm

Allergan

Noven Therapeutics

Xianju Pharma

Novo Nordisk

Zhejiang Aisheng

Reproductive Hormone Segment by Type

Estrogen and Progesterone

Testosterone

Reproductive Hormone Segment by Application

Hospitals

Clinics

Other

Reproductive Hormone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Reproductive Hormone status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Reproductive Hormone key companies, revenue, market share, and recent developments.

3. To split the Reproductive Hormone breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Reproductive Hormone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Reproductive Hormone significant trends, drivers, influence factors in global and regions.

6. To analyze Reproductive Hormone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Reproductive Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Reproductive Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Reproductive Hormone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Reproductive Hormone industry.

Chapter 3: Detailed analysis of Reproductive Hormone company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Reproductive Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Reproductive Hormone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Reproductive Hormone Industry Trends Table 2. Reproductive Hormone Industry Drivers Table 3. Reproductive Hormone Industry Opportunities and Challenges Table 4. Reproductive Hormone Industry Restraints Table 5. Global Reproductive Hormone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Reproductive Hormone Revenue Share by Company (2021-2026) Table 7. Global Reproductive Hormone Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Reproductive Hormone Key Company Manufacturing Base & Headquarters Table 9. Global Reproductive Hormone Company, Product Type & Application Table 10. Global Reproductive Hormone Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Reproductive Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Estrogen and Progesterone Table 15. Significant Companies of Testosterone Table 16. Global Reproductive Hormone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Reproductive Hormone Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Reproductive Hormone Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Reproductive Hormone Sales Value Share by Type (2021-2026) Table 20. Global Reproductive Hormone Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Clinics Table 23. Significant Companies of Other Table 24. Global Reproductive Hormone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Reproductive Hormone Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Reproductive Hormone Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Reproductive Hormone Sales Value Share by Application (2021-2026) Table 28. Global Reproductive Hormone Sales Value Share by Application (2027-2032) Table 29. Global Reproductive Hormone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Reproductive Hormone Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Reproductive Hormone Sales Value Share by Region (2021-2026) Table 32. Global Reproductive Hormone Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Reproductive Hormone Sales Value Share by Region (2027-2032) Table 34. Global Reproductive Hormone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Reproductive Hormone Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Reproductive Hormone Sales Value Market Share by Country (2021-2026) Table 37. Global Reproductive Hormone Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Reproductive Hormone Sales Value Market Share by Country (2027-2032) Table 39. Pfizer Company Information Table 40. Pfizer Business Overview Table 41. Pfizer Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Pfizer Reproductive Hormone Product Portfolio Table 43. Pfizer Recent Development Table 44. MERCK Groups Company Information Table 45. MERCK Groups Business Overview Table 46. MERCK Groups Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. MERCK Groups Reproductive Hormone Product Portfolio Table 48. MERCK Groups Recent Development Table 49. ABBVIE Company Information Table 50. ABBVIE Business Overview Table 51. ABBVIE Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. ABBVIE Reproductive Hormone Product Portfolio Table 53. ABBVIE Recent Development Table 54. Bayer Company Information Table 55. Bayer Business Overview Table 56. Bayer Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Bayer Reproductive Hormone Product Portfolio Table 58. Bayer Recent Development Table 59. Endo Pharmaceuticals Company Information Table 60. Endo Pharmaceuticals Business Overview Table 61. Endo Pharmaceuticals Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Endo Pharmaceuticals Reproductive Hormone Product Portfolio Table 63. Endo Pharmaceuticals Recent Development Table 64. Mayne Pharma Company Information Table 65. Mayne Pharma Business Overview Table 66. Mayne Pharma Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Mayne Pharma Reproductive Hormone Product Portfolio Table 68. Mayne Pharma Recent Development Table 69. Jenapharm Company Information Table 70. Jenapharm Business Overview Table 71. Jenapharm Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Jenapharm Reproductive Hormone Product Portfolio Table 73. Jenapharm Recent Development Table 74. Allergan Company Information Table 75. Allergan Business Overview Table 76. Allergan Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Allergan Reproductive Hormone Product Portfolio Table 78. Allergan Recent Development Table 79. Noven Therapeutics Company Information Table 80. Noven Therapeutics Business Overview Table 81. Noven Therapeutics Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Noven Therapeutics Reproductive Hormone Product Portfolio Table 83. Noven Therapeutics Recent Development Table 84. Xianju Pharma Company Information Table 85. Xianju Pharma Business Overview Table 86. Xianju Pharma Reproductive Hormone Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Xianju Pharma Reproductive Hormone Product Portfolio Table 88. Xianju Pharma Recent Development Table 89. Novo Nordisk Company Information Table 90. Novo Nordisk Business Overview Table 91. Novo Nordisk Reproductive Hormone Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Novo Nordisk Reproductive Hormone Product Portfolio Table 93. Novo Nordisk Recent Development Table 94. Zhejiang Aisheng Company Information Table 95. Zhejiang Aisheng Business Overview Table 96. Zhejiang Aisheng Reproductive Hormone Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Zhejiang Aisheng Reproductive Hormone Product Portfolio Table 98. Zhejiang Aisheng Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Reproductive Hormone Product Image Figure 2. Global Reproductive Hormone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Reproductive Hormone Market Size (2021-2032) & (US$ Million) Figure 4. Global Reproductive Hormone Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Estrogen and Progesterone Image Figure 8. Testosterone Image Figure 9. Global Reproductive Hormone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Reproductive Hormone Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Reproductive Hormone Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Clinics Image Figure 14. Other Image Figure 15. Global Reproductive Hormone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Reproductive Hormone Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Reproductive Hormone Sales Value Share by Application (2021-2032) Figure 18. Global Reproductive Hormone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Reproductive Hormone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Reproductive Hormone Sales Value (2021-2032) & (US$ Million) Figure 21. North America Reproductive Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Reproductive Hormone Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Reproductive Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Reproductive Hormone Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Reproductive Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Reproductive Hormone Sales Value (2021-2032) & (US$ Million) Figure 27. South America Reproductive Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Reproductive Hormone Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Reproductive Hormone Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Reproductive Hormone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Reproductive Hormone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Reproductive Hormone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Estrogen and Progesterone
  • Testosterone
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Pfizer
  • MERCK Groups
  • ABBVIE
  • Bayer
  • Endo Pharmaceuticals
  • Mayne Pharma
  • Jenapharm
  • Allergan
  • Noven Therapeutics
  • Xianju Pharma
  • Novo Nordisk
  • Zhejiang Aisheng

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Reproductive Hormone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Reproductive Hormone Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Reproductive Hormone Market Dynamics
  1. 2.1 Reproductive Hormone Industry Trends
  2. 2.2 Reproductive Hormone Industry Drivers
  3. 2.3 Reproductive Hormone Industry Opportunities and Challenges
  4. 2.4 Reproductive Hormone Industry Restraints
3 Reproductive Hormone Market by Company
  1. 3.1 Global Reproductive Hormone Company Revenue Ranking in 2025
  2. 3.2 Global Reproductive Hormone Revenue by Company (2021-2026)
  3. 3.3 Global Reproductive Hormone Company Ranking (2024-2026)
  4. 3.4 Global Reproductive Hormone Company Manufacturing Base and Headquarters
  5. 3.5 Global Reproductive Hormone Company Product Type and Application
  6. 3.6 Global Reproductive Hormone Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Reproductive Hormone Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Reproductive Hormone Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Reproductive Hormone Market by Type
  1. 4.1 Reproductive Hormone Type Introduction
  2. 4.1.1 Estrogen and Progesterone
  3. 4.1.2 Testosterone
  4. 4.2 Global Reproductive Hormone Sales Value by Type
  5. 4.2.1 Global Reproductive Hormone Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Reproductive Hormone Sales Value by Type (2021-2032)
  7. 4.2.3 Global Reproductive Hormone Sales Value Share by Type (2021-2032)
5 Reproductive Hormone Market by Application
  1. 5.1 Reproductive Hormone Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Reproductive Hormone Sales Value by Application
  6. 5.2.1 Global Reproductive Hormone Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Reproductive Hormone Sales Value by Application (2021-2032)
  8. 5.2.3 Global Reproductive Hormone Sales Value Share by Application (2021-2032)
6 Reproductive Hormone Regional Value Analysis
  1. 6.1 Global Reproductive Hormone Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Reproductive Hormone Sales Value by Region (2021-2032)
  3. 6.2.1 Global Reproductive Hormone Sales Value by Region: 2021-2026
  4. 6.2.2 Global Reproductive Hormone Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Reproductive Hormone Sales Value (2021-2032)
  7. 6.3.2 North America Reproductive Hormone Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Reproductive Hormone Sales Value (2021-2032)
  10. 6.4.2 Europe Reproductive Hormone Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Reproductive Hormone Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Reproductive Hormone Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Reproductive Hormone Sales Value (2021-2032)
  16. 6.6.2 South America Reproductive Hormone Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Reproductive Hormone Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Reproductive Hormone Sales Value Share by Country, 2025 VS 2032
7 Reproductive Hormone Country-level Value Analysis
  1. 7.1 Global Reproductive Hormone Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Reproductive Hormone Sales Value by Country (2021-2032)
  3. 7.2.1 Global Reproductive Hormone Sales Value by Country (2021-2026)
  4. 7.2.2 Global Reproductive Hormone Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Reproductive Hormone Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Reproductive Hormone Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Reproductive Hormone Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Reproductive Hormone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Reproductive Hormone Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Reproductive Hormone Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Reproductive Hormone Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Reproductive Hormone Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Reproductive Hormone Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Reproductive Hormone Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Reproductive Hormone Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Reproductive Hormone Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Reproductive Hormone Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Reproductive Hormone Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Reproductive Hormone Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Reproductive Hormone Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Reproductive Hormone Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Reproductive Hormone Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Reproductive Hormone Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Reproductive Hormone Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Reproductive Hormone Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Reproductive Hormone Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Reproductive Hormone Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Reproductive Hormone Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Reproductive Hormone Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Reproductive Hormone Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Reproductive Hormone Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Reproductive Hormone Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Reproductive Hormone Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Reproductive Hormone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Reproductive Hormone Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Reproductive Hormone Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 MERCK Groups
  8. 8.2.1 MERCK Groups Company Information
  9. 8.2.2 MERCK Groups Business Overview
  10. 8.2.3 MERCK Groups Reproductive Hormone Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MERCK Groups Reproductive Hormone Product Portfolio
  12. 8.2.5 MERCK Groups Recent Developments
  13. 8.3 ABBVIE
  14. 8.3.1 ABBVIE Company Information
  15. 8.3.2 ABBVIE Business Overview
  16. 8.3.3 ABBVIE Reproductive Hormone Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ABBVIE Reproductive Hormone Product Portfolio
  18. 8.3.5 ABBVIE Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Reproductive Hormone Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Reproductive Hormone Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Endo Pharmaceuticals
  26. 8.5.1 Endo Pharmaceuticals Company Information
  27. 8.5.2 Endo Pharmaceuticals Business Overview
  28. 8.5.3 Endo Pharmaceuticals Reproductive Hormone Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Endo Pharmaceuticals Reproductive Hormone Product Portfolio
  30. 8.5.5 Endo Pharmaceuticals Recent Developments
  31. 8.6 Mayne Pharma
  32. 8.6.1 Mayne Pharma Company Information
  33. 8.6.2 Mayne Pharma Business Overview
  34. 8.6.3 Mayne Pharma Reproductive Hormone Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mayne Pharma Reproductive Hormone Product Portfolio
  36. 8.6.5 Mayne Pharma Recent Developments
  37. 8.7 Jenapharm
  38. 8.7.1 Jenapharm Company Information
  39. 8.7.2 Jenapharm Business Overview
  40. 8.7.3 Jenapharm Reproductive Hormone Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jenapharm Reproductive Hormone Product Portfolio
  42. 8.7.5 Jenapharm Recent Developments
  43. 8.8 Allergan
  44. 8.8.1 Allergan Company Information
  45. 8.8.2 Allergan Business Overview
  46. 8.8.3 Allergan Reproductive Hormone Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Allergan Reproductive Hormone Product Portfolio
  48. 8.8.5 Allergan Recent Developments
  49. 8.9 Noven Therapeutics
  50. 8.9.1 Noven Therapeutics Company Information
  51. 8.9.2 Noven Therapeutics Business Overview
  52. 8.9.3 Noven Therapeutics Reproductive Hormone Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Noven Therapeutics Reproductive Hormone Product Portfolio
  54. 8.9.5 Noven Therapeutics Recent Developments
  55. 8.10 Xianju Pharma
  56. 8.10.1 Xianju Pharma Company Information
  57. 8.10.2 Xianju Pharma Business Overview
  58. 8.10.3 Xianju Pharma Reproductive Hormone Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Xianju Pharma Reproductive Hormone Product Portfolio
  60. 8.10.5 Xianju Pharma Recent Developments
  61. 8.11 Novo Nordisk
  62. 8.11.1 Novo Nordisk Company Information
  63. 8.11.2 Novo Nordisk Business Overview
  64. 8.11.3 Novo Nordisk Reproductive Hormone Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novo Nordisk Reproductive Hormone Product Portfolio
  66. 8.11.5 Novo Nordisk Recent Developments
  67. 8.12 Zhejiang Aisheng
  68. 8.12.1 Zhejiang Aisheng Company Information
  69. 8.12.2 Zhejiang Aisheng Business Overview
  70. 8.12.3 Zhejiang Aisheng Reproductive Hormone Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zhejiang Aisheng Reproductive Hormone Product Portfolio
  72. 8.12.5 Zhejiang Aisheng Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst